180 Life Sciences To Conduct Reverse Stock Split Of Its Outstanding Shares Of Common Stock At 1-For-19 Ratio
Portfolio Pulse from Benzinga Newsdesk
180 Life Sciences plans a reverse stock split at a 1-for-19 ratio, effective February 28, 2024, to meet Nasdaq's minimum bid price requirement for continued listing.
February 26, 2024 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
180 Life Sciences (ATNF) to undergo a 1-for-19 reverse stock split to comply with Nasdaq's minimum bid price, effective Feb 28, 2024.
The reverse stock split is a strategic move by 180 Life Sciences to increase its stock price above the $1.00 minimum bid price required by Nasdaq for continued listing. This action typically results in a short-term increase in stock price due to the reduced number of shares outstanding, making it more attractive to investors and helping the company to meet Nasdaq's listing requirements.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100